Acute motor axonal neuropathy associated with COVID-19


Ateş M. P. , Çetin B. N. , Ertuǧrul B. N. , Yüksektepe A. E. , Çomoǧlu S. S.

Journal of Experimental and Clinical Medicine (Turkey), vol.39, no.1, pp.277-279, 2022 (Refereed Journals of Other Institutions) identifier

  • Publication Type: Article / Article
  • Volume: 39 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.52142/omujecm.39.1.52
  • Title of Journal : Journal of Experimental and Clinical Medicine (Turkey)
  • Page Numbers: pp.277-279
  • Keywords: acute motor axonal neuropathy, COVID-19, guillain-Barré syndrome, pandemic, SARS-CoV2

Abstract

© 2022 Ondokuz Mayis Universitesi. All rights reserved.COVID-19, which is considered a global pandemic, is constantly being renewed. Acute motor axonal neuropathy (AMAN) is a rare, axonal variant of Guillain-Barré syndrome (GBS). This article presents a 69-year-old female patient diagnosed with AMAN due to a COVID-19 infection. Sixty-nine-year-old female patient who started myalgia, headache, cough 14 days ago, and was added diarrhea, fever, loss of smell and taste. Nasopharyngeal SARS-CoV-2 polymerase chain reaction (PCR) was found to be positive. Ten days later, numbness and weakness developed in the distal extremities. As a result of the patient's neurological examination, acute motor axonal neuropathy (AMAN) was diagnosed.